ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,678, issued on Oct. 14, was assigned to CRODA KOREA LTD (Iksan-si, South Korea).

"Sphingolipid, and dermatologic composition comprising same for external application" was invented by Kwanhyoung Lee (Yongin-si, South Korea), Ara Kim (Yongin-si, South Korea), Jihye Han (Yongin-si, South Korea), Sojung Lim (Yongin-si, South Korea), Juyeon Lee (Yongin-si, South Korea), Heesun Kim (Yongin-si, South Korea), Youngbeom Kim (Yongin-si, South Korea) and Daebang Seo (Yongin-si, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A novel sphingolipid is disclosed. The novel sphingolipid is in liquid form at room temperature due to a low melting point, an...